X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-achievement-of-28-day-post-infusion-milestone-for-first-us-patient-dosed-in-phase-1-clinical-trial-of-cd19-car-t-cell-therapy-for-lupus-nephritis-301925488.html
https://endpts.com/bain-capital-co-leads-60m-financing-for-kyvernas-car-t-work-in-autoimmune-diseases/
https://www.clinicaltrialsarena.com/news/fda-kyverna-lupus-nephritis-trial/
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-fda-clearance-of-ind-for-kyv-101-a-novel-fully-human-cd19-car-t-cell-therapy-to-treat-lupus-nephritis-301675192.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-submits-ind-for-novel-car-t-cell-therapy-to-treat-lupus-nephritis-301651246.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-names-peter-maag-phd-as-chief-executive-officer-301647891.html#:~:text=EMERYVILLE%2C%20Calif.%2C%20Oct.,chief%20executive%20officer%20(CEO).
https://www.prnewswire.com/news-releases/kyverna-therapeutics-names-peter-maag-phd-as-chief-executive-officer-301647891.html
https://www.contractpharma.com/contents/view_breaking-news/2022-08-26/kyverna-therapeutics-appoints-tom-van-blarcom-as-svp-and-head-of-research/?widget=listSection
https://www.prnewswire.com/news-releases/kyverna-therapeutics-names-cell-therapy-expert-tom-van-blarcom-phd-as-senior-vice-president-head-of-research-301610099.html
Market Place
Share 
